Miguel Coelho

Company: PhoreMost Ltd

Job title: Associate Director

Seminars:

Using PROTEINi® to Develop Novel Degraders: Assays & Principles 10:00 am

• Phenotypic screening for protein degraders using PhoreMost’s PROTEINi technology has identified several novel bio-active degron peptides and their corresponding E3 ligases • Target-specific screening allows the development of biological bifunctional protein degrader molecules • We’ll show how the PROTEINi-E3 ligase interaction is used to inform and accelerate the development of small molecules that interact…Read more

day: Day Two